El NASDAQ, peor día desde JUNIO: el dinero HUYE de la IA… y corre a los BONOS
5 extracted signals · 0 resolved · 5 still active
Jon EconomistIndependent analyst profile- Source published
- 23 Oct 2026, 08:28 UTC
- Recorded by Tahlil Plus
- 23 Oct 2026, 12:01 UTC

AI-generated source summary
The market is showing bearish sentiment across multiple assets, including BTCUSDT, META, TSLA, MRNA, and PG, with targets indicating further downside potential. These assets are either in a bearish trend or showing signs of weakening, with price levels identified for potential entries and invalidation points. For example, BTCUSDT is currently bearish and its target is 78,000, with failure at 83,000. META is also bearish with a target of 600, failing at 670. TSLA is bearish with a target of 350, failing at 390. MRNA is bearish with a target of 180, failing at 220. PG is bearish with a target of 155, failing at 170. XOM, however, is showing bullish signals and is being monitored for potential further upside, though it is currently in a bearish trend. The overall market sentiment, as indicated by the fear and greed index, is in the 'fear' zone, suggesting a predominantly bearish outlook for riskier assets.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source





Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
5 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
5 signals remain active.
Jon Economist
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.